DMK Pharmaceuticals Corporation (DMKPQ)

DMK Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Cash & Equivalents	6.66	1.11	23.25	6.75	8.81	19.27
Cash & Cash Equivalents	6.66	1.11	23.25	6.75	8.81	19.27
Cash Growth	171.99%	-95.22%	244.51%	-23.40%	-54.28%	5.12%
Receivables	0	1.05	5.9	0.24	1.88	1.16
Inventory	0.66	1.24	0.42	1.23	2.06	3.28
Other Current Assets	0.55	5.87	5.63	4.31	1.13	2.08
Total Current Assets	7.87	9.27	35.2	12.52	13.88	25.78
Property, Plant & Equipment	1.08	1.61	2.99	3.47	13.54	9.87
Goodwill and Intangibles	0	0	0	0	18.77	20.85
Other Long-Term Assets	0.01	0.05	0.11	14.88	1.65	1.85
Total Long-Term Assets	1.09	1.66	3.09	18.34	33.96	32.57
Total Assets	8.96	10.93	38.3	30.87	47.84	58.36
Accounts Payable	9.97	7.94	3.75	1.78	4.27	4.17
Deferred Revenue	0.33	0.21	0.85	0.95	0.92	1.01
Current Debt	0.06	0.34	0.35	2.63	2.6	2.58
Other Current Liabilities	3.1	2.91	6.27	14.57	1.63	3.79
Total Current Liabilities	13.46	11.4	11.22	19.93	9.41	11.55
Long-Term Debt	0	0	0.34	1.58	1.48	0
Other Long-Term Liabilities	0.46	0.19	0.85	5.86	3.95	0.11
Total Long-Term Liabilities	0.46	0.19	1.19	7.44	5.43	0.11
Total Liabilities	13.92	11.58	12.42	27.37	14.84	11.67
Total Debt	0.06	0.34	0.69	4.21	4.08	2.58
Debt Growth	-85.37%	-50.53%	-83.55%	3.21%	57.90%	-49.02%
Retained Earnings	-323.47	-304.56	-278.09	-229.91	-180.52	-153
Shareholders' Equity	-5.29	-0.81	25.88	3.5	33	46.69
Net Cash / Debt	6.6	0.77	22.56	2.54	4.73	16.69
Net Cash / Debt Growth	227.09%	-96.59%	788.46%	-46.34%	-71.65%	25.80%
Net Cash Per Share	0.93	0.36	10.95	2.29	6.22	29.89
Working Capital	-5.59	-2.12	23.98	-7.4	4.47	14.23
Book Value Per Share	-0.75	-0.38	12.57	3.16	43.37	83.62

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).